knowledge -WSS

knowledge

author：hotspot 2025-08-26 07:42:45 - browse：11

Illustration oh researchers look up at a blister pill pac. Part of the blister pack is filled with pills, while the center shows a sketch of a brain. -- biotech coverage from STAT — Mike Reddy for STAT

One by one, the companies behind Zoloft, Prozac, and Paxil soured on psychiatry.

It was the early 2000s, and as America warmed to the sounds of Sisqó and Shakira, the world’s largest pharmaceutical firms were running out of ideas to treat mental illness. Their blockbuster treatments for depression and schizophrenia had reshaped society and made billions of dollars in the process, but the old cash cows were soon to go generic. Efforts to one-up the last generation of drugs mostly resulted in incremental changes to aging medicines. And when insurance companies balked at paying brand-name prices for extended-release generics, the money dried up and the industry moved out.

“The mindset of Big Pharma in those days was one pill for millions and millions of people,” said John LaMattina, who led Pfizer’s research division from 1999 to 2007. “Everyone was looking for the next Lipitor, and when that fizzled out, there was an exodus out of psychotherapeutic areas.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Trans patients at the end of life deserve respect and dignity

WSS

Ambulance rides for just $100? Advisers want major billing fixes

Republicans love RFK Jr. What's that tell us about health in 2024?

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

FDA advisory panel to debate high blood pressure devices

FDA advisory panel to debate high blood pressure devices

National associations that represent hospice owe an apology

leisure time

knowledge

knowledge

At least 13 dead in Texas as scorching temps continue

10 million people disenrolled from Medicaid over past six months

Alkermes shareholders re

Extreme heat events are a public health emergency

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Listen: Vivek Ramaswamy's star turn & leaky drug data

Medicare details structure of new drug price negotiation program

Medicare will require more price transparency from hospitals

As demand for Covid shots wanes, Moderna seeks its next success

National associations that represent hospice owe an apology

knowledge

Removing probiotics from the NICU could threaten preemies' health

Victims of gun violence feel impacts long after bullet wound

As obesity drug market grows, telehealth companies court payers

Medicare solvency divides Republicans at the presidential debate

Intellia plays down concerns on accidental germline transmission

Will General Catalyst be the first of many hospital takeovers?

entertainment

hotspot

hotspot

knowledge